Paramount Peptides presents research-grade Retatrutide, a novel triple agonist peptide targeting GIP, GLP-1, and GCG receptors. This lyophilized powder offers researchers a powerful tool for studying metabolic regulation mechanisms.
The compound demonstrates exceptional receptor activation properties, with particular emphasis on GIP receptor interaction. This multi-target approach provides comprehensive metabolic effects including appetite suppression, glycemic control, and enhanced energy expenditure through fat oxidation.
Key research applications include:
• Investigation of GIP receptor activation pathways and appetite regulation mechanisms
• Study of GLP-1 mediated glycemic control and gastric emptying effects
• Research into GCG receptor stimulation and thermogenic fat conversion processes
Our Paramount Peptides Retatrutide is manufactured under strict quality controls to ensure consistent purity and performance in research settings. The lyophilized form provides excellent stability and convenient reconstitution for laboratory use.
For research purposes only. Not for human consumption or diagnostic use. Proper laboratory safety protocols should always be followed when handling research peptides.